No. |
Product Name |
CAS No. |
Spec |
Price |
|
| 1478312 |
Olanzapine Related Compound A (20 mg) (5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile) |
138564-59-7 |
|
|
| 1478323 |
Olanzapine Related Compound B (15 mg) (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one) |
221176-49-4 |
|
|
| 1478334 |
Olanzapine Related Compound C (5 mg) (COLD SHIPMENT REQUIRED) (2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4’-N-oxide) |
174794-02-6 |
|
|
| 1478367 |
Olmesartan Medoxomil (100 mg) |
144689-63-4 |
|
|
| 1478378 |
Olmesartan Medoxomil Related Compound A (20 mg) (1-{[2’-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one) |
849206-43-5 |
|
|
| 1478403 |
Olopatadine Hydrochloride (150 mg) |
140462-76-6 |
|
|
| 1478425 |
Olopatadine Related Compound B (35 mg) ((Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide) |
173174-07-7 |
|
|
| 1478436 |
Olopatadine Related Compound C (35 mg) ((11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid) |
55453-87-7 |
|
|
| 1478491 |
Omeprazole Related Compound F and G Mixture (25 mg) |
N/A |
|
|
| 1478505 |
Omeprazole (200 mg) |
73590-58-6 |
|
|
| 1478516 |
Omeprazole Related Compound A (15 mg) (Omeprazole Sulfone or 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole) |
88546-55-8 |
|
|
| 1478527 |
Omeprazole Related Compound E (15 mg) (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide) |
176219-04-8 |
|
|
| 1478549 |
Omeprazole Magnesium (10 mg) |
95382-33-5 |
|
|
| 1478561 |
Omeprazole Related Compound I (15 mg) (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide) |
158812-85-2 |
|
|
| 1478571 |
Ondansetron (300 mg) |
99614-02-5 |
|
|
| 1478582 |
Ondansetron Hydrochloride (300 mg) |
103639-04-9 |
|
|
| 1478593 |
Ondansetron Related Compound A (50 mg) (3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride) |
119812-29-2 |
|
|
| 1478618 |
Ondansetron Related Compound C (30 mg) (1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one) |
27397-31-1 |
|
|
| 1478629 |
Ondansetron Related Compound D (30 mg) (1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one) |
N/A |
|
|
| 1478630 |
Ondansetron Resolution Mixture (50 mg) |
N/A |
|
|
